Skip to content

iQuit in practice: a study to examine a personalised web-and text message programme to support smoking cessation in Primary Care

A randomised controlled trial to assess the feasibility, acceptability and effectiveness of tailored web- and text-based facilitation of smoking cessation in primary care

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN56702353
Enrollment
600
Registered
2009-03-02
Start date
2009-04-01
Completion date
Unknown
Last updated
2018-10-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Smoking cessation Mental and Behavioural Disorders Mental and behavioural disorders due to use of tobacco

Interventions

Two groups to be compared: 1. Control group: participants will receive 'usual care' for smoking cessation 2. Intervention group: participants will receive 'usual care' for smoking cessation, plus a pr

Sponsors

University of Cambridge (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients can be included in the study if they meet all of the criteria below: 1. Current smoker (has smoked in the 7 days prior to randomisation date) 2. Able to read English and can provide written informed consent 3. Is seriously considering quitting smoking and is willing to set a quit date within the 14 days after randomisation 4. Aged 18 - 75 years, either sex 5. Has a mobile phone and is familiar with sending and receiving SMS text messages 6. Is willing to participate in study and follow study procedures 7. Is not currently enrolled in another formal smoking cessation study or program 8. Is not using nicotene replacement therapy (NRT), bupropion (Zyban®) and varenicline (Champix®) or other pharmacotherapy at randomisation date

Exclusion criteria

Exclusion criteria: 1. Do not meet all of the inclusion criteria 2. Considered by their GP to be unsuitable for the project for any reason e.g. people with severe mental impairment or severely or terminally ill Co-morbidities, for example chronic obstructive pulmonary disease (COPD), diabetes, are not excluded from the study (unless their GP considers them unsuitable). In addition, we would not exclude entry to the trial of more than one participant per household, however, should this occur, they would be assigned to the same treatment group (to minimise the potential for contamination).

Design outcomes

Primary

MeasureTime frame
Self-reported effectiveness, using a self report of being abstinent from smoking for at least 2 weeks, at 8-week follow-up from randomisation date, as assessed by postal questionnaire or telephone interview (blinded interviewer).

Secondary

MeasureTime frame
1. Carbon monoxide (CO)-verified self-report of being abstinent from smoking for at least 2 weeks, at 4-week follow-up from quit date 2. Self-reported prolonged abstinence (at least 3 months) at 6-month follow-up from randomisation date

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 23, 2026